- Report
- August 2022
Global
From €754EUR$790USD£632GBP
- Report
- August 2022
Global
From €754EUR$790USD£632GBP
- Report
- August 2022
Global
From €754EUR$790USD£632GBP
- Report
- October 2023
- 105 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2024
- 83 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- May 2022
- 68 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2022
- 265 Pages
Global
From €3407EUR$3,570USD£2,855GBP
The Dementia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Dementia drugs are used to treat the cognitive decline associated with Alzheimer's disease, vascular dementia, and other forms of dementia. These drugs are typically prescribed to improve memory, thinking, and behavior, as well as to slow the progression of the disease. Common dementia drugs include cholinesterase inhibitors, memantine, and glutamate modulators.
Some companies in the Dementia Drug market include Pfizer, Novartis, Merck, and Eli Lilly. Other companies include Biogen, AstraZeneca, and Johnson & Johnson. Show Less Read more